Timothy A Yap

Scientific Advisor at I-Mab Biopharma

Dr. Yap’s main research focuses on the first-in-human and combinatorial development of molecularly targeted agents and immunotherapies, and their acceleration through clinical studies using novel predictive and pharmacodynamics biomarkers.

Org chart

Howard L. Weiner

Scientific Advisor

Pamela M. Klein

Interim Chairperson

Wei Fu

Director

Patricia LoRusso

Scientific Advisor

Roy S. Herbst

Scientific Advisor

Conor Chia-hung Yang

Independent Director

Chun Kwok Alan Au

Independent Director

Rong Shao

Independent Director

Teams

+6

Board of Directors

9 members

Timeline

  • Scientific Advisor

    Current role